rs34745867

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_015488.5(PNKD):​c.652C>A​(p.Arg218Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.023 in 1,613,408 control chromosomes in the GnomAD database, including 522 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 26 hom., cov: 32)
Exomes 𝑓: 0.024 ( 496 hom. )

Consequence

PNKD
NM_015488.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.31

Publications

6 publications found
Variant links:
Genes affected
PNKD (HGNC:9153): (PNKD metallo-beta-lactamase domain containing) This gene is thought to play a role in the regulation of myofibrillogenesis. Mutations in this gene have been associated with the movement disorder paroxysmal non-kinesigenic dyskinesia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
CATIP-AS2 (HGNC:41079): (CATIP antisense RNA 2)
MIR6810 (HGNC:49987): (microRNA 6810) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.19).
BP6
Variant 2-218342015-C-A is Benign according to our data. Variant chr2-218342015-C-A is described in ClinVar as Benign. ClinVar VariationId is 334323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.31 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.017 (2583/152304) while in subpopulation NFE AF = 0.0287 (1953/68012). AF 95% confidence interval is 0.0277. There are 26 homozygotes in GnomAd4. There are 1165 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2583 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015488.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNKD
NM_015488.5
MANE Select
c.652C>Ap.Arg218Arg
synonymous
Exon 7 of 10NP_056303.3
PNKD
NM_022572.4
c.580C>Ap.Arg194Arg
synonymous
Exon 6 of 9NP_072094.1Q8N490-3
CATIP-AS2
NR_125777.1
n.120+9145G>T
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNKD
ENST00000273077.9
TSL:1 MANE Select
c.652C>Ap.Arg218Arg
synonymous
Exon 7 of 10ENSP00000273077.4Q8N490-1
PNKD
ENST00000258362.7
TSL:1
c.580C>Ap.Arg194Arg
synonymous
Exon 6 of 9ENSP00000258362.3Q8N490-3
PNKD
ENST00000685415.1
c.769C>Ap.Arg257Arg
synonymous
Exon 8 of 11ENSP00000510415.1A0A8I5KXK0

Frequencies

GnomAD3 genomes
AF:
0.0170
AC:
2583
AN:
152186
Hom.:
26
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00410
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.00963
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.0233
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0287
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.0159
AC:
4009
AN:
251396
AF XY:
0.0158
show subpopulations
Gnomad AFR exome
AF:
0.00412
Gnomad AMR exome
AF:
0.00480
Gnomad ASJ exome
AF:
0.00486
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0242
Gnomad NFE exome
AF:
0.0268
Gnomad OTH exome
AF:
0.0173
GnomAD4 exome
AF:
0.0237
AC:
34558
AN:
1461104
Hom.:
496
Cov.:
31
AF XY:
0.0232
AC XY:
16888
AN XY:
726918
show subpopulations
African (AFR)
AF:
0.00350
AC:
117
AN:
33472
American (AMR)
AF:
0.00528
AC:
236
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00513
AC:
134
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.00177
AC:
153
AN:
86250
European-Finnish (FIN)
AF:
0.0272
AC:
1454
AN:
53418
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5762
European-Non Finnish (NFE)
AF:
0.0281
AC:
31271
AN:
1111274
Other (OTH)
AF:
0.0194
AC:
1169
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1637
3275
4912
6550
8187
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1104
2208
3312
4416
5520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0170
AC:
2583
AN:
152304
Hom.:
26
Cov.:
32
AF XY:
0.0156
AC XY:
1165
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00409
AC:
170
AN:
41578
American (AMR)
AF:
0.00961
AC:
147
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4830
European-Finnish (FIN)
AF:
0.0233
AC:
247
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0287
AC:
1953
AN:
68012
Other (OTH)
AF:
0.0123
AC:
26
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
138
276
413
551
689
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0207
Hom.:
39
Bravo
AF:
0.0146
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.0237
EpiControl
AF:
0.0228

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Paroxysmal nonkinesigenic dyskinesia 1 (2)
-
-
1
Paroxysmal nonkinesigenic dyskinesia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.19
CADD
Benign
11
DANN
Benign
0.82
PhyloP100
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34745867; hg19: chr2-219206738; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.